Cancer Immunotherapy

Cancer immunotherapy is the use of the immune system to treat cancer. Immunotherapies can be broadly categorized into active, passive or hybrid (active and passive). These techniques exploit the fact that cancer cells often have molecules on their surface that can be identified by the immune system, known as tumour-associated antigens (TAAs); they are often proteins or other macromolecules (e.g. carbohydrates). Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

  • Monoclonal antibodies
  • Immune checkpoint inhibitors
  • Cancer vaccines

Related Conference of Cancer Immunotherapy

September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

9th European Immunology Conference

June 14-16, 2018 Rome, Italy

Cancer Immunotherapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in